The alternative strategy is to localize disease-related sequence variation based entirely on its location or position in the genome. Before GWAS, available methods included the genomewide linkage study (GWLS) and linkage disequilibrium (LD) mapping (of which GWAS is a large-scale example). (See Table 1 for definitions, and Table 2 for a timeline of critical developments.)
